Glucagon like peptide 1中文 Glucagon-like peptide-1 (GLP-1) drugs have emerged as a significant therapeutic class, primarily used for managing type 2 diabetes and, increasingly, for weight loss. These medications mimic the action of the naturally occurring GLP-1 hormone, which plays a crucial role in regulating blood glucose levels and promoting satiety. The growing popularity and expanding applications of GLP-1 agonists have made them a focal point in discussions about metabolic health, with many individuals seeking to understand their benefits, mechanisms, and available optionsA10 —DRUGSUSED IN DIABETES · A10B — BLOOD GLUCOSE LOWERINGDRUGS, EXCL. INSULINS · A10BJ —Glucagon-like peptide-1(GLP-1) analogues.Drugs.Drug,Drug....
GLP-1 receptor agonists work by binding to GLP-1 receptors in the body, thereby stimulating a cascade of beneficial effects.作者：K Dungan·被引用次数：38—Compoundeddrugs– Compoundeddrugs, includingGLP-1... Like Peptide-1 Receptor Agonists Reported to the US Food andDrugAdministration. Their primary actions include:
* Stimulating Insulin Release: When blood glucose levels are high, GLP-1 drugs prompt the pancreas to release more insulin, which helps lower glucose by facilitating its uptake into cellsOzempic and Rybelsus are brand names for the drug semaglutide. Although someGLP-1 medicationsare given via injection, they are different medications to ....
* Reducing Glucagon Secretion: They also suppress the release of glucagon, a hormone that raises blood glucose levels, further contributing to glycemic control.
* Slowing Gastric Emptying: GLP-1 agonists slow down the rate at which the stomach empties its contents into the small intestine. This leads to a more gradual absorption of nutrients and a feeling of fullness, which can aid in appetite control and weight management.
* Promoting Satiety: By acting on the brain, these drugs can increase feelings of fullness and reduce hunger, making it easier to manage food intakeFor the relatedmedications, seeGLP-1receptor agonist and Dipeptidyl peptidase-4 inhibitor. ... "Monster DietDrugsLike Ozempic Started With Actual Monsters"..
The landscape of GLP-1 drugs includes several well-known medications, each with specific indications and formulations.2025年5月21日—What areGLP-1 medications? ... GLP-1s are drugs that help people manage diabetes and lose weight. Their surging popularity has a range of ... These drugs are typically administered via injection, though oral formulations are also available.
* Semaglutide: Marketed under brand names like Ozempic (for type 2 diabetes) and Wegovy (for chronic weight management), semaglutide has gained significant attention for its efficacy. Rybelsus is an oral formulation of semaglutide for type 2 diabetes.
* Liraglutide: Available as Victoza (for type 2 diabetes) and Saxenda (for weight management), liraglutide was one of the earlier GLP-1 agonists approved for these conditions.
* Dulaglutide: Known as Trulicity, this medication is primarily used for type 2 diabetes management.
* Tirzepatide: While technically a dual GIP/GLP-1 receptor agonist, tirzepatide (Mounjaro for type 2 diabetes, Zepbound for weight loss) has demonstrated significant efficacy in both blood sugar control and weight reduction, often considered within the broader category due to its GLP-1 componentGlucagon-Like Peptide-1 Receptor Agonists - StatPearls - NCBI.
While GLP-1 drugs offer substantial benefits, they are not without considerations.
Clinical trials have consistently shown that GLP-1 agonists are highly effective in improving glycemic control in individuals with type 2 diabetes.How does Ozempic work? Understanding GLP-1s for ... Their impact on weight loss has also been a major driver of their increased use, with many patients experiencing significant reductions in body weight.
Common side effects of GLP-1 drugs are often gastrointestinal in nature and can include nausea, vomiting, diarrhea, constipation, and abdominal painWHO issues global guideline on the use of GLP-1 .... These are typically mild to moderate and tend to decrease over time as the body adjusts to the medication. More serious, though rare, side effects can include pancreatitis, gallbladder problems, and kidney issues.
GLP-1 drugs are generally not recommended for individuals with a history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2.作者：JM Friedman·2024·被引用次数：42—The discovery and development ofGLP-1baseddrugsthat have revolutionized the treatment of obesity ... The modifieddrugwould need to remain ... Pregnant or breastfeeding individuals should discuss the risks and benefits with their healthcare provider, as the safety data in these populations is limited. It's crucial for patients to take these medications only under the guidance of a healthcare professionalGLP-1 medicines, contraception and pregnancy. All individuals of child-bearing potential (who are able to become pregnant) usingGLP-1 medicationsshould take ....
Research into GLP-1 drugs is ongoing, exploring their potential benefits beyond diabetes and weight management, such as cardiovascular health and neuroprotection. The development of new formulations, including oral options and longer-acting injectables, continues to improve patient convenience and adherence. The expanding landscape also includes investigational drugs like orforglipron, which are being studied for their potential to further advance treatment options.
In conclusion, glucagon-like peptide-1 (GLP-1) drugs represent a significant advancement in the treatment of type 2 diabetes and obesity作者：R Darwish·2025·被引用次数：1—The SURPASS clinical development program established tirzepatideasthe most effective glucose-loweringmedicationever developed [29]. SURPASS-2 provided .... Their ability to mimic a key hormone involved in glucose regulation and appetite control has led to remarkable improvements in patient outcomes.GLP-1 medications, or GLP-1 agonists, are a class of drugs used to treat type 2 diabetes and obesity. They are often injectable medications that are combined ... As research progresses and new medications become available, GLP-1 drugs are poised to play an even more integral role in metabolic health management.2025年10月29日—Subscribe to our newsletter for the latestmedicationnews, newdrugapprovals and FDA alerts.Drugs.com provides accurate and independent ...
Join the newsletter to receive news, updates, new products and freebies in your inbox.